When fighting advanced cancers with targeted therapies, precision matters. Braftovi 75 mg is one such medication that zeroes in on specific mutations in cancer cells, offering hope where traditional treatments may fall short. This guide will break down what Braftovi is, how it works, who it’s for, how to take it, potential side effects, and what patients and providers should know before starting treatment.

What Is Braftovi?

Braftovi (generic name: encorafenib) is an oral kinase inhibitor designed to target the BRAF V600E mutation. This mutation is commonly found in certain cancers, such as metastatic melanoma and metastatic colorectal cancer. By blocking the abnormal BRAF protein, Braftovi slows down or stops the growth of cancer cells.

While Braftovi 75 mg is often used in combination with other therapies (such as binimetinib for melanoma), its standalone role in treatment continues to evolve in cancer care.

Who Is The Medicine For?

The Braftovi indication approved by the FDA includes:

• Metastatic melanoma with BRAF V600E or V600K mutations (used in combination with binimetinib)
• Metastatic colorectal cancer with BRAF V600E mutation (used with cetuximab)
  

Before prescribing, oncologists perform genetic testing to confirm the presence of the BRAF mutation. If the mutation is absent, Braftovi is not indicated.

How to Take Braftovi 75 mg

Knowing how to take Braftovi is crucial for safety and effectiveness. The typical starting dose is 75 mg taken once or twice daily, depending on the cancer type and combination with other drugs.

Braftovi can be taken with or without food, but it should be taken at the same time(s) each day. 

Do not crush or chew the capsule. If you miss a dose, take it as soon as you remember unless it’s close to your next scheduled dose. Do not double up.

Always follow your oncologist’s instructions carefully, as dosage adjustments may be needed based on how your body responds or if you experience side effects.

Braftovi Side Effects: What to Expect

Like most cancer medications, Braftovi 75 can cause side effects, some mild, others more serious. Here’s a breakdown of the most commonly reported Braftovi side effects:

Common Side Effects:

• Fatigue
• Nausea or vomiting
• Diarrhea
• Abdominal pain
• Joint pain
• Skin rash
• Photosensitivity (sensitivity to sunlight)
  

Serious Side Effects (less common but possible):

• Bleeding issues
• Heart rhythm changes (QT prolongation)
• Liver toxicity
• Eye problems (blurred vision or retinal detachment)
• New skin cancers (cutaneous squamous cell carcinoma)
  

Report any unusual symptoms to your healthcare provider right away, especially if you experience vision changes, chest pain, or severe abdominal discomfort.

Braftovi Cost and Insurance Considerations

The Braftovi cost can vary significantly depending on your insurance plan, pharmacy, and whether you’re taking it alone or with other medications. On average, a month’s supply of Braftovi can cost several thousand dollars without insurance coverage.

To make this treatment more accessible, patients can explore:

• Insurance coverage: Most major insurance plans cover Braftovi for its approved indications.
• Patient assistance programs: The manufacturer, Pfizer, may offer support programs for eligible patients.
• Braftovi coupon options: Savings programs and Braftovi coupons may be available through manufacturer websites or specialty pharmacies.
  

For accurate pricing and financial support options, speak with your healthcare provider or pharmacist.

Monitoring and Follow-Up

Patients on Braftovi 75 mg require regular monitoring, including:

• Blood tests: To check liver function and other blood parameters.
• Skin exams: To monitor for new skin cancers.
• Eye exams: If vision problems occur.
  

If you’re combining Braftovi with other targeted therapies, your oncologist will closely track side effects and treatment response to adjust dosages as needed.

Start Treatment Today

Braftovi 75 mg offers a targeted approach to treating cancers driven by the BRAF V600 mutation, giving eligible patients a more precise, effective option than chemotherapy alone. While side effects are possible, close monitoring and expert medical guidance help manage them effectively.

Whether you’re a patient considering treatment or a caregiver looking for answers, knowing what Braftovi is, how it works, and how to take it safely empowers you to make informed decisions on your care journey.

Looking to get started or need more information? Visit our Braftovi Product Page for full product details, ordering options, and support resources.

Frequently Asked Questions (FAQs)

How long do you stay on Braftovi treatment?

Treatment duration varies by patient and cancer type. Some may stay on Braftovi for several months to years, depending on how well the cancer responds and if side effects remain manageable. Your oncologist will regularly evaluate your progress and adjust your treatment plan as needed.

Can Braftovi be taken alone?

Braftovi is usually taken in combination with other medications, such as binimetinib for melanoma or cetuximab for colorectal cancer. It is not typically used as a standalone treatment unless specifically directed by a healthcare provider.

Does Braftovi cause hair loss?

Hair thinning or hair loss is not a common side effect of Braftovi, but some patients may experience changes in hair texture or mild shedding. If this occurs, consult your doctor, as it could be due to other medications or overall cancer treatment.